Hogy Medical dividend calculator – Hogy Medical Co Ltd Declares 20.0 Cash Dividend
June 12, 2023
🌥️Dividends Yield
On June 1, 2023, Hogy Medical ($TSE:3593) Co Ltd declared a 20.0 cash dividend. This is a great opportunity for those looking to invest in dividend stocks as the company has paid an annual dividend of 70.0, 68.0, and 68.0 JPY per share in the last three years. The yields for those years have been 2.2%, 2.03%, and 1.93%, with an average yield of 2.05%. This marks a great return for shareholders who have held the stock for the past few years, and provides an attractive opportunity for new investors looking for a reliable dividend stock.
The ex-dividend date for the 20.0 cash dividend is June 29, 2023. So, if you’re in the market for dividend stocks, HOGY MEDICAL should be considered.
Stock Price
The announcement sent shockwaves throughout the stock market, with HOGY MEDICAL stock opening at JP¥3195.0 and closing at JP¥3185.0, a drop of 0.2% from the previous closing price of 3190.0. This dividend is an indication of the financial health and success of HOGY MEDICAL, and investors are sure to reap the benefits of this decision in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Hogy Medical. More…
| Total Revenues | Net Income | Net Margin |
| 38.5k | 4.39k | 11.4% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Hogy Medical. More…
| Operations | Investing | Financing |
| 8.84k | -3.55k | -7.25k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Hogy Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 101.23k | 17.11k | 3.47k |
Key Ratios Snapshot
Some of the financial key ratios for Hogy Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 1.6% | 11.9% | 16.8% |
| FCF Margin | ROE | ROA |
| 16.0% | 4.8% | 4.0% |
Analysis
At GoodWhale, we conducted an analysis of HOGY MEDICAL to get a better understanding of its wellbeing. After careful examination, our Risk Rating indicates that HOGY MEDICAL is a medium risk investment in terms of financial and business aspects. In addition, our analysis revealed one risk warning in the income sheet. If you’d like to take a closer look, all you have to do is register on GoodWhale.com. Here, you’ll be able to access our detailed findings and gain a deeper understanding of the risks associated with investing in HOGY MEDICAL. More…
Peers
With each company offering unique products and services, the competition between them is fierce, with each striving to outdo the others in terms of quality, performance and cost.
– Olympus Corp ($TSE:7733)
Olympus Corp is a global leader in the medical technology industry. The company develops and manufactures innovative medical imaging, endoscopy, and surgical instruments and systems. As of 2023, the company has a market cap of 3.05 trillion, indicating its strong presence in the industry. Additionally, Olympus Corp’s Return on Equity (ROE) stands at 18.32%, representing a healthy level of profitability for the company. This suggests that Olympus has been successful in leveraging its shareholders’ investments to generate significant returns.
– Asahi Intecc Co Ltd ($TSE:7747)
Asahi Intecc Co Ltd is a Japanese medical device company that develops, manufactures, and sells medical devices including catheters, guidewires, stents, and sutures. As of 2023, the company has a market cap of 625.55B, indicating its strong financial performance. Additionally, the company’s Return on Equity (ROE) stands at 8.71%, which is well above the industry average. This is a testament to the company’s efficient use of shareholder funds and its commitment to creating value for its investors.
– Tristel PLC ($LSE:TSTL)
Tristel PLC is a UK-based company that provides infection prevention and contamination control products and services. Its products are used in healthcare, food production and veterinary sectors as well as in other industries. As of 2023, Tristel PLC has a market cap of 162.96M. This value is determined by the total value of its outstanding shares. Additionally, the company has a Return on Equity (ROE) of 3.72%, which measures its profitability by comparing its net income to the amount of shareholder equity. This figure indicates that Tristel PLC is generating a reasonable return on its investments.
Summary
Investing in HOGY MEDICAL can be a reliable and profitable strategy for investors who are looking for consistent returns. In the past three years, the company has provided an average dividend of 68 JPY per share, with a yield of 2.05%. This dividend yield is above average relative to those of similar companies, making it a good choice for investors seeking steady income.
Additionally, HOGY MEDICAL has a history of consistent dividend payments and has generated solid returns over the past three years. With its strong performance and stability, investing in this company could be a wise decision.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
